We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
George Mason University’s CAP-CLIA Lab Uses Aushon’s Array Technology
News

George Mason University’s CAP-CLIA Lab Uses Aushon’s Array Technology

George Mason University’s CAP-CLIA Lab Uses Aushon’s Array Technology
News

George Mason University’s CAP-CLIA Lab Uses Aushon’s Array Technology

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "George Mason University’s CAP-CLIA Lab Uses Aushon’s Array Technology"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

In a cooperative effort to promote the development of personalized medicine based on reverse-phase protein array technology, Aushon BioSystems has placed a 2470 Arrayer in a CAP-CLIA laboratory established by George Mason University.

Mason’s CAP-CLIA laboratory, under the direction of Profs. Lance Liotta and Emanuel Petricoin, is focused on trials of clinical cancer treatments based on an individual’s unique protein expression profile. The new 2470 Arrayer joins several other 2470s in service at Mason.

Dr. John Austin, Co-Founder and President of Aushon BioSystems, said “We are very pleased to assist Mason with the development of this ground-breaking application of personalized medicine using protein expression.”

Dr. Lance Liotta, co-Director of Mason’s Center for Applied Proteomics and Molecular Medicine, added: “We believe that the 2470 arrayer is a superior platform that will provide the highest quality data for our translational work, and are very excited to be able to collaborate with Aushon.”

Advertisement